Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lineage Cell Therapeutics Inc. Director's Dealing 2012

Jul 31, 2012

6895_dirs_2012-07-31_7b68fa01-1071-490c-a049-f72b7119a0f9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOTIME INC (BTX)
CIK: 0000876343
Period of Report: 2012-07-30

Reporting Person: GREENBELT CORP /NY (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-06-01 Common Shares, no par value G 2000 Disposed 1968505 Direct

Footnotes

F1: During June 2012, Greenbelt Corp. gifted 2,000 common shares.